Trust Company of Vermont’s Teva Pharmaceuticals TEVA Stock Holding History

Trust Company of Vermont’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-41	Closed	-$739	–	1114
2024 Q3	$739	Hold	41	–	–	﹤0.01%	995
2024 Q2	$666	Hold	41	–	–	﹤0.01%	849
2024 Q1	$579	Buy	+41	New	+$579	﹤0.01%	813
2021 Q3	–	Sell	-49	Closed	–	–	663
2021 Q2	$0	Hold	49	–	–	﹤0.01%	799
2021 Q1	$1K	Hold	49	–	–	﹤0.01%	748
2020 Q4	$0	Hold	49	–	–	﹤0.01%	787
2020 Q3	$0	Hold	49	–	–	﹤0.01%	788
2020 Q2	$1K	Hold	49	–	–	﹤0.01%	756
2020 Q1	$0	Hold	49	–	–	﹤0.01%	943
2019 Q4	$0	Hold	49	–	–	﹤0.01%	960
2019 Q3	$0	Hold	49	–	–	﹤0.01%	1035
2019 Q2	$0	Hold	49	–	–	﹤0.01%	1046
2019 Q1	$1K	Hold	49	–	–	﹤0.01%	957
2018 Q4	$1K	Sell	49 -603	-92%	-$12.3K	﹤0.01%	968
2018 Q3	$14K	Hold	652	–	–	﹤0.01%	752
2018 Q2	$16K	Hold	652	–	–	﹤0.01%	739
2018 Q1	$11K	Hold	652	–	–	﹤0.01%	744
2017 Q4	$12K	Sell	652 -1,180	-64%	-$21.7K	﹤0.01%	735
2017 Q3	$33K	Sell	1,832 -10,805	-86%	-$195K	﹤0.01%	567
2017 Q2	$420K	Sell	12,637 -5,100	-29%	-$170K	0.04%	237
2017 Q1	$570K	Sell	17,737 -4,497	-20%	-$145K	0.06%	200
2016 Q4	$806K	Buy	22,234 +7,229	+48%	+$262K	0.09%	169
2016 Q3	$691K	Buy	15,005 +1,105	+8%	+$50.9K	0.09%	166
2016 Q2	$698K	Buy	13,900 +100	+0.7%	+$5.02K	0.09%	159
2016 Q1	$739K	Buy	13,800 +700	+5%	+$37.5K	0.1%	153
2015 Q4	$860K	Sell	13,100 -904	-6%	-$59.3K	0.12%	146
2015 Q3	$791K	Sell	14,004 -60	-0.4%	-$3.39K	0.12%	151
2015 Q2	$831K	Buy	14,064 +373	+3%	+$22K	0.12%	154
2015 Q1	$853K	Hold	13,691	–	–	0.12%	150
2014 Q4	$788K	Hold	13,691	–	–	0.11%	156
2014 Q3	$736K	Sell	13,691 -277	-2%	-$14.9K	0.11%	151
2014 Q2	$732K	Buy	13,968 +507	+4%	+$26.6K	0.11%	151
2014 Q1	$711K	Buy	13,461 +71	+0.5%	+$3.75K	0.12%	150
2013 Q4	$537K	Buy	13,390 +1,396	+12%	+$56K	0.09%	160
2013 Q3	$454K	Buy	11,994 +900	+8%	+$34.1K	0.08%	166
2013 Q2	$435K	Buy	+11,094	New	+$435K	0.08%	158